Ubs Group Ag Morphic Holding, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 41,460 shares of MORF stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,460

Previous 148,994 72.17%

Holding current value

$2.36 Million

Previous $5.24 Million 73.07%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$26.12 - $34.07 $2.81 Million - $3.66 Million	-107,534 Reduced 72.17%	41,460 $1.41 Million
Q1 2024 May 13, 2024	BUY	$26.64 - $40.31 $1.5 Million - $2.28 Million	56,441 Added 60.98%	148,994 $5.24 Million
Q4 2023 Feb 09, 2024	BUY	$19.95 - $31.0 $965,659 - $1.5 Million	48,404 Added 109.64%	92,553 $2.67 Million
Q3 2023 Nov 09, 2023	BUY	$21.33 - $59.42 $547,455 - $1.53 Million	25,666 Added 138.86%	44,149 $1.01 Million
Q2 2023 Aug 11, 2023	BUY	$34.33 - $62.11 $617,219 - $1.12 Million	17,979 Added 3567.26%	18,483 $1.06 Million
Q1 2023 May 12, 2023	SELL	$26.01 - $48.69 $354,802 - $664,180	-13,641 Reduced 96.44%	504 $18,000
Q4 2022 Feb 08, 2023	BUY	$24.14 - $30.37 $341,460 - $429,583	14,145 New	14,145 $378,000
Q2 2022 Aug 10, 2022	SELL	$19.74 - $43.01 $26,708 - $58,192	-1,353 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $49,046 - $70,383	1,353 New	1,353 $54,000
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $1.2 Million - $1.83 Million	-27,819 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $1.36 Million - $1.71 Million	25,348 Added 1025.82%	27,819 $1.58 Million
Q2 2021 Aug 13, 2021	BUY	$45.13 - $64.99 $81,324 - $117,111	1,802 Added 269.36%	2,471 $142,000
Q1 2021 May 12, 2021	SELL	$29.77 - $84.85 $65,553 - $186,839	-2,202 Reduced 76.7%	669 $42,000
Q4 2020 Feb 11, 2021	SELL	$25.66 - $34.55 $203,278 - $273,705	-7,922 Reduced 73.4%	2,871 $96,000
Q3 2020 Nov 12, 2020	BUY	$22.51 - $30.11 $146,089 - $195,413	6,490 Added 150.83%	10,793 $295,000
Q2 2020 Jul 31, 2020	SELL	$12.65 - $29.57 $29,929 - $69,962	-2,366 Reduced 35.48%	4,303 $116,000
Q1 2020 May 01, 2020	SELL	$10.84 - $20.85 $17,701 - $34,048	-1,633 Reduced 19.67%	6,669 $98,000
Q4 2019 Feb 14, 2020	BUY	$13.02 - $19.5 $38,760 - $58,051	2,977 Added 55.91%	8,302 $142,000
Q3 2019 Nov 14, 2019	BUY	$17.46 - $29.05 $89,430 - $148,794	5,122 Added 2523.15%	5,325 $96,000
Q2 2019 Aug 14, 2019	BUY	$18.0 - $19.82 $3,654 - $4,023	203 New	203 $4,000

Others Institutions Holding MORF

# of Institutions

140

Shares Held

38.7M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account